UPLC-ESI-MS/MS study of the effect of green tea extract on the oral bioavailability of erlotinib and lapatinib in rats: potential risk of pharmacokinetic interaction

Abahussain, Hadir M. Maher, Nourah Z. Alzoman, Shereen M. Shehata, Ashwag O. . 2017

رقم المجلد

1049-1050

مجلة/صحيفة

Journal of Chromatography B

الصفحات

30-40

مزيد من المنشورات

UPLC-ESI-MS/MS study of the effect of green tea extract on the oral bioavailability of erlotinib and lapatinib in rats: potential risk of pharmacokinetic interaction

بواسطة Hadir M. Maher, Nourah Z. Alzoman, Shereen M. Shehata, Ashwag O. Abahussain

2017

Comparative pharmacokinetic profiles of selected irreversible tyrosine kinase inhibitors, neratinib and pelitinib, with apigenin in rat plasma by UPLC-MS/MS

tNeratinib (NER) and pelitinib (PEL) are irreversible tyrosine kinase inhibitors (TKIs) that have beenrecently employed in cancer treatment. Apigenin (API), among other flavonoids, is known to…

بواسطة Hadir M. Maher, Nourah Z. Alzoman, Shereen M. Shehata, Ashwag O. Abahussain

2017

Simultaneous estimation of four new direct acting antiviral agents in pharmaceutical formulations by HPLC-DAD method

Background: Ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak®) are the newest medicines approved for use in the treatment of hepatitis C virus (HCV) and are available in tablet form as an…

بواسطة Nourah Z. Al-Zoman, Hadir M. Maher, Amal Al-Subaie

2017

Hadir Mohamed Maher Shalaby

UPLC-ESI-MS/MS study of the effect of green tea extract on the oral bioavailability of erlotinib and lapatinib in rats: potential risk of pharmacokinetic interaction

Abahussain, Hadir M. Maher, Nourah Z. Alzoman, Shereen M. Shehata, Ashwag O. . 2017